Full Committee Markup of "H.R. 4771, H.R. 4250, H.R. 594, H.R. 669, H.R. 4290, H.R. 4450, and H.R. 5057," (July 14-15, 2014)
The Committee on Energy and Commerce began a markup on Monday, July 14, 2014. The Committee considered the following:
• H.R. 4771, Designer Anabolic Steroid Control Act;
• H.R. 4250, Sunscreen Innovation Act, as amended;
• H.R. 594, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014, as amended;
• H.R. 669, Sudden Unexpected Death and Data Enhancement and Awareness Act, as amended;
• H.R. 4290, Wakefield Act of 2014, as amended;
• H.R. 4450, Travel Promotion, Enhancement, and Modernization Act of 2014, as amended; and,
• H.R. 5057, EPS Service Parts Act of 2014
On Monday, July 14, the Subcommittee convened at 4:00 p.m. in 2123 Rayburn House Office Building for opening statements only. It reconvened on Tuesday, July 15, at 10:00 a.m. in 2123 Rayburn House Office Building.
Documents
Opening Statement of Ranking Member Henry A. Waxman, as prepared for delivery.
Transcript (July 14, 2014)
Transcript (July 15, 2014)
H.R. 4771, Designer Anabolic Steroid Control Act, favorably forwarded, as amended, by voice vote.
Amendment by Rep. Pitts, passed by voice vote.
H.R. 669, Sudden Unexpected Death and Data Enhancement and Awareness Act, favorably forwarded by voice vote.
H.R. 4290, Wakefield Act of 2014, favorably forwarded by voice vote.
H.R. 4450, Travel Promotion, Enhancement, and Modernization Act of 2014, favorably forwarded, as amended, by voice vote.
Amendment by Reps. Bilirakis and Schakowsky, passed by voice vote.
H.R. 4250, Sunscreen Innovation Act, favorably forwarded, as amended, by voice vote.
Amendment by Rep. Whitfield (AINS), passed by voice vote.
Amendment by Rep. Dingell to AINS, passed by voice vote.
H.R. 594, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2014, favorably forwarded, as amended, by voice vote.
Amendment by Rep. Burgess, passed by voice vote.
H.R. 5057, EPS Service Parts Act of 2014, favorably forwarded by voice vote.
Webcast
Opening Statements (July 14, 2014)
Bill Considerations (July 15, 2014)
Bill Text of H.R. 4771, the "Designer Anabolic Steroid Control Act" (May 29, 2014).